Empa researchers from the nanotech@surfaces laboratory have experimentally recreated two fundamental quantum physics models originally inspired b ...

Executive SummaryThe biopharma process equipment market is poised for rapid expansion, projected to reach USD 33.2 billion by ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

Download Kerala Plus Two Chemistry Question Paper 2025 and Answer Key PDF. Get the official and unofficial solutions to ...

Based on extensive preclinical studies, MRANK-106 is differentiated from other WEE1 inhibitors in development by its: Dual targeting of WEE1 and YES1 kinases, providing synergistic anti-tumor effects ...

This study reports valuable findings on the role of Layilin in the motility and suppressive capacity of clonal expanded regulatory T cells (Tregs) in the skin. Although the strength of the study is ...

A paper from 2018 in the American Journal of Cancer Research piqued his interest when he read that a little-known molecule ...

SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

The FDA approval announcement came in on January 30, 2025 as part of particular status granted to the molecule (the application received breakthrough therapy, fast track and priority review ...